share_log

4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

4: Statement of changes in beneficial ownership of securities-Director YALE PHYLLIS R

4:持股變動聲明-董事 YALE PHYLLIS R
美股SEC公告 ·  10/02 17:49

Moomoo AI 已提取核心訊息

Phyllis R. Yale, a reporting person for Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock on September 30, 2024. The details of the transaction, including the number of shares, nature of the shares, transaction price, and post-transaction holdings, have not been disclosed. This financial activity is relevant to investors monitoring insider actions within Bristol-Myers Squibb, a leading pharmaceutical company.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb (BMY), has engaged in a transaction involving the company's stock on September 30, 2024. The details of the transaction, including the number of shares, nature of the shares, transaction price, and post-transaction holdings, have not been disclosed. This financial activity is relevant to investors monitoring insider actions within Bristol-Myers Squibb, a leading pharmaceutical company.
Phyllis R. Yale,施貴寶(BMY)的一名報告人,於2024年9月30日進行了涉及該公司股票的交易。交易的詳細信息,包括股份數量、股票性質、交易價格和交易後持股量,並未公開。這一財務活動對於監控施貴寶這家領先的藥品公司內部行動的投資者而言是相關的。
Phyllis R. Yale,施貴寶(BMY)的一名報告人,於2024年9月30日進行了涉及該公司股票的交易。交易的詳細信息,包括股份數量、股票性質、交易價格和交易後持股量,並未公開。這一財務活動對於監控施貴寶這家領先的藥品公司內部行動的投資者而言是相關的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息